Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events?

por Haji, Alhan, Alkattan, Abdallah, Mahmoud, Nagla, Elkagam, Elfadil, Hassanein, Mustafa, Alfaifi, Amal, Al-Tawfiq, Jaffar A., Alabdulkareem, Khaled, Jokhdar, Hani, Radwan, Nashwa
Publicado 2023

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit

por Kandeel, Mahmoud, Yamamoto, Mizuki, Tani, Hideki, Kobayashi, Ayako, Gohda, Jin, Kawaguchi, Yasushi, Park, Byoung Kwon, Kwon, Hyung-Joo, Inoue, Jun-ichiro, Alkattan, Abdallah
Publicado 2021